Literature DB >> 2113105

New viral diseases. A real and potential problem without boundaries.

E D Kilbourne1.   

Abstract

Viruses are the most mutable and rapidly evolving human parasites. Therefore, it is not surprising that new virus diseases, such as the acquired immunodeficiency syndrome, are emerging. However, these new viruses are relatively few in number, which reflects the constraints placed on viral evolution by the requirement for maintenance of virus structure and function and virus adaptation to restricted ecologic sites. Most "new" viral diseases, such as the hemorrhagic fevers, result from environmental disruptions that increase human contact with animals or insect vectors of old viruses. However, truly novel viruses with lethal potential or capacity for global spread have emerged in animals as a consequence of single-point mutations or genetic recombination between viruses. Given the mutability of viruses and the inevitability of environmental change, we must be prepared for the evolution of new virus diseases.

Entities:  

Mesh:

Year:  1990        PMID: 2113105     DOI: 10.1001/jama.264.1.68

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  5 in total

1.  Pathology and emerging infections--quo vadimus?

Authors:  D A Schwartz; R T Bryan; J M Hughes
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

Review 2.  [How to define the species barrier to pathogen transmission?].

Authors:  Philippe Sansonetti
Journal:  Bull Acad Natl Med       Date:  2006-03       Impact factor: 0.144

Review 3.  Cross-species transfer of viruses: implications for the use of viral vectors in biomedical research, gene therapy and as live-virus vaccines.

Authors:  Derrick Louz; Hans E Bergmans; Birgit P Loos; Rob C Hoeben
Journal:  J Gene Med       Date:  2005-10       Impact factor: 4.565

4.  Preparing for emerging infections.

Authors:  G A Gellert
Journal:  Nature       Date:  1994-08-11       Impact factor: 49.962

5.  Leptospirosis prevalence in a population of yucatan, Mexico.

Authors:  Navarrete Espinosa Joel; Moreno Muñoz Maribel; Rivas Sánchez Beatriz; Velasco Castrejón Oscar
Journal:  J Pathog       Date:  2011-11-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.